4th Quarter - Report

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

Period 4th Quarter 2024 Filed Jan 19, 2025 Signed by Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals

Official filing
Firm
ACADIA PHARMACEUTICALS
Client
ACADIA PHARMACEUTICALS
Income
—
Expenses
$510,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of the Inflation Reduction Act of 2022; Issues Related to the Orphan Drug Tax Credit; Help Copays Act (HR 830 / S 1375); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); The Creating Hope Reauthorization Act (HR 7384 / S 4583) / HR 3433); BIOSECURE Act (HR 7085); The American Recovery Act (HR 10545).

LobbyistCovered position, as disclosed
MICHAEL MATTOON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3433 (118th), H.R. 10545 (118th), H.R. 830 (118th), H.R. 6094 (118th), H.R. 7384 (118th), H.R. 2365 (118th), H.R. 7085 (118th), H.R. 5539 (118th)

Medicare/Medicaid MMM

Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174); BIOSECURE Act (HR 7085); The Mini Act (HR 5547 / S 476).

LobbyistCovered position, as disclosed
MICHAEL MATTOON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6094 (118th), H.R. 2365 (118th), H.R. 7174 (118th), H.R. 5539 (118th), H.R. 7085 (118th), H.R. 4096 (118th), H.R. 5547 (118th)

Trade (domestic/foreign) TRD

BIOSECURE Act (HR 7085).

LobbyistCovered position, as disclosed
MICHAEL MATTOON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7085 (118th)

Taxation/Internal Revenue Code TAX

Issues related to the Orphan Drug Tax Credit.

LobbyistCovered position, as disclosed
MICHAEL MATTOON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.